FDA Import Refusal 799-7740274-2/11/1 — NOVO NORDISK
The FDA refused shipment 799-7740274-2/11/1 from NOVO NORDISK (Canada) on Nov 9, 2023. The refused product falls under Drugs and Biologics — ROSIGLITAZONE MALEATE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 9, 2023
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY71 ROSIGLITAZONE MALEATE (ANTI-DIABETIC)
- Charges
- 75